HORMONAL THERAPY IN CANCER OF THE BREAST. XXII. EFFECT OF 17ALPHA-METHYL-5BETA-DIHYDROTESTOSTERONE ON CLINICAL COURSE AND HORMONAL EXCRETION.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • Additional Information
    • Source:
      Publisher: Wiley Country of Publication: United States NLM ID: 0374236 Publication Model: Print Cited Medium: Print ISSN: 0008-543X (Print) Linking ISSN: 0008543X NLM ISO Abbreviation: Cancer Subsets: OLDMEDLINE
    • Publication Information:
      Publication: <2005- >: Hoboken, NJ : Wiley
      Original Publication: New York [etc.] Published for the American Cancer Society by J. Wiley [etc.]
    • Subject Terms:
    • Contributed Indexing:
      Keywords: 17-KETOSTEROIDS*; ANDROGENS*; BREAST NEOPLASMS*; CREATINE AND CREATININE*; DESOXYCORTICOSTERONE*; GONADOTROPINS*; LH*; LYMPHATIC METASTASIS*; PREGNANEDIOL*; PROLACTIN*; URINE*
    • Accession Number:
      0 (17-Ketosteroids)
      0 (Androgens)
      0 (Gonadotropins)
      08J2K08A3Y (Dihydrotestosterone)
      40GP35YQ49 (Desoxycorticosterone)
      9002-62-4 (Prolactin)
      9002-67-9 (Luteinizing Hormone)
      AYI8EX34EU (Creatinine)
      JR3JD1Y22C (Pregnanediol)
      MU72812GK0 (Creatine)
    • Publication Date:
      Date Created: 19630901 Date Completed: 19961201 Latest Revision: 20190620
    • Publication Date:
      20231215
    • Accession Number:
      10.1002/1097-0142(196309)16:9<1113::aid-cncr2820160905>3.0.co;2-n
    • Accession Number:
      14062538